The company that produces the tablets has said the medication is mislabeled with the incorrect strength on the carton.

has expanded its recall of Clonazepam Orally Disintegrating Tablets (C-IV), according to the U.S. Food and Drug Administration. The recalled drugs were mislabeled with the incorrect strength on ...

is expanding its previously announced voluntary recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) due to potential product carton strength mislabeling. Specifically, Endo's ongoing ...

(OTCQX: NDOI) ("Endo") announced today that one of its operating subsidiaries, Endo USA, Inc., is expanding its previously announced voluntary recall of Clonazepam Orally Disintegrating Tablets, USP ...

(OTCQX: NDOI) (“Endo”) announced today that one of its operating subsidiaries, Endo USA, Inc., is expanding its previously announced voluntary recall of Clonazepam Orally Disintegrating Tablets, USP ...

Endo USA is expanding its previous recall of orally disintegrating clonazepam tablets to include more than a dozen additional product lots, the company said in a notice posted on the FDA’s ...

Abby Reinhard is a writer, editor, and native Jersey Girl. Before Best Life, she was working in medical writing, ...